Contrasting Incidences Along with Descriptive Markers in the Epidemiology of Melanoma

References

• UICC (Union Internationale Contre le Cancer). Cancer incidence in five continents. A technical report, R Doll, P Payne, J Waterhouse. Springer Verlag, Berlin 1966
   Google Scholar
• UICC (Union Internationale Contre le Cancer). Cancer incidence in five continents, R Doll, C S Muir, J Waterhouse. Springer Verlag, Berlin 1970; Vol II
   Google Scholar
• WHO/IARC (World Health Organization/International Agency for Research on Cancer). Cancer incidence in five continents, J Waterhouse, C S Muir, P Correa, P Powell. Scientific Publications, LyonFrance 1976; Vol. III, nr. 15
   Google Scholar
• WHO/IARC/IACR (World Health Organization/International Agency for Research on Cancer/International Association of Cancer Registries). Cancer incidence in five continents, J Waterhouse, C S Muir, K Shanmugaratnam, J Powell. IARC Scientific Publications, LyonFrance 1982; Vol. IV, nr. 42CII5CIV
   Google Scholar
• Doll R. The epidemiology of cancer. Cancer 1980; 45: 2475–85
   PubMed Web of Science ®Google Scholar
• Venzon D J, Moolgavkar S. H. Cohort Analysis of malignant melanoma in five countries. Am J Epidemiol 1984; 119: 62–70
   PubMed Web of Science ®Google Scholar
• Balmukhanov S B, Nugmanov S N, Smirnov V. A. (1966) Epidemiology of melanoma in Central Asia. Pigment cell conference (IUCC). 1966, G Delia Porta, O Mühlbock. Springer Verlag, 308–311
   Google Scholar
• Movshovitz M, Modan B. Role of sun exposure in the etiology of malignant melanoma: epidemiologic inference. J Natl Cancer Inst 1973; 51: 777–9
   PubMed Web of Science ®Google Scholar
• Higginson J. Environmental carcinogenesis: A global perspective. Environmental carcinogenesis, P Emmelot, E Kriek. Elsevier/North Holland Biomedical Press, Amsterdam 1979; 9–24
   Google Scholar
• McGovern V. J. Melanoblastoma. Med J Aust 1952; 1: 39–42
   Google Scholar
• Lancaster H O, Nelson J. Sunlight as a cause of melanoma: a clinical survey. Med J Aust 1957; 1: 452–6
   Google Scholar
• Kripke M. L. Speculations on the role of ultraviolet radiation in the development of malignant melanoma. J Natl Cancer Inst 1979; 63: 541–8
   PubMedGoogle Scholar
• Holman C DJ, Armstrong B K, Heenan P. J. The theory of the etiology and pathogenesis of human cutaneous malignant melanoma. J Natl Cancer Inst 1983; 71: 651–6
   PubMedGoogle Scholar
• Scotto J, Nam J-M. Skin melanoma and seasonal patterns. Am J Epidemiol 1980; 111: 309–14
   Google Scholar
• McGovern V. J. Epidemiological aspects of melanoma: A review. Pathology 1977; 9: 233–41
   Web of Science ®Google Scholar
• Stukonis M. K. Cancer incidence cumulative rate—IARC International Technical Report 78–002. IARC-Lyon-France. 1978
   Google Scholar
• Boyle P, Day N E, Magnus K. Mathematical modelling of malignant melanoma trends in Norway, 1953–1978. Am J Epidemiol 1983; 118: 887–96
   PubMed Web of Science ®Google Scholar
• Jensen O M, Bolander A. M. Trends in malignant melanoma of the skin. World Health Statistics Quarterly Report 1980; 33: 2–26
   PubMedGoogle Scholar
• Ohsumi T, Seiji M. Statistical study on malignant melanoma in Japan (1970–1976). Tohoku J Exp Med 1977; 121: 355–64
   Google Scholar
• Soeripto Jensen O M, Muir C. S. Cancer in Yogyakarta, Indonesia: Relative frequencies. Br J Cancer 1977; 36: 141
   Google Scholar
• Muir C S, Shanmugaratnam K, Tan K. K. Incidence rates for microscopically diagnosed cancer in the Singapore population 1960–1964. Singapore Med J 1971; 12: 323–32
   Google Scholar
• Pour P, Tantachamrum T, Althoff J, et al. Melanoma in the North of Thailand in the last ten years. Z Krebsforsch 1973; 80: 31–5
   Google Scholar
• Clemmessen J. Statistical studies in the aetiology of malignant neoplasm III, Denmark 1958–62. Acta Pathol & Microbiol Scand 1969; 209(suppl.)171
   Google Scholar
• Beardmore G. L. The epidemiology of malignant melanoma in Australia. Melanoma and skin cancer, W H McCarthy. Government Printer, Sydney, New South Wales 1972; 39–64
   Google Scholar
• Balch Ch M, Karakousis C, Mettlin C, et al. Management of cutaneous melanoma in the United States. Surg Gynecol Obstet 1984; 158: 311–8
   Google Scholar
• Larsen T E, Grude T. H. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical Stage 1. Acta Pathol Microbiol Scand Sect A 1978; 86: 513–22
   Google Scholar
• Larsen T E, Grude T. H. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical Stage I. Acta Pathol Microbiol Scand Sect A 1979; 87: 469–77
   Google Scholar
• Muir C S, Nectoux J. International patterns of cancer in cancer epidemiology and prevention, Ch. VII, D Schottenfeld, J F Fraumeni, C Y Saunders. Saunders Cy, Philadelphia 1982; 119–37
   Google Scholar
• Nabil El-Bolkainy M, Ebeid A. M. Malignant melanoma in Egypt. Tumori 1973; 59: 429–36
   Google Scholar
• Giraud R MA, Rippey E, Rippey J. J. Malignant melanoma of the skin in black Africans. S Afr Med J 1975; 49: 665
   PubMed Web of Science ®Google Scholar
• Ch I Saacson, Selzer G, Keye V, et al. Cancer in the urban blacks of South Africa. Zuid-Afr Kank Bull 1978; 22: 49–84
   Google Scholar
• Lewis M. G. Malignant melanoma in Uganda. Br J Cancer 1967; 21: 483–495
   Google Scholar
• Reintgen D, McCarty K M, Cox E, et al. Malignant melanoma in black American and white American populations. JAMA 1982; 248: 1856–9
   PubMed Web of Science ®Google Scholar
• Lee J AH, Petersen G R, Stevens R G, et al. The influence of age, year of birth, and date on mortality from malignant melanoma in the populations of England and Wales, Canada, and the white population of the United States. Am J Epidemiol 1979; 110: 734–9
   PubMed Web of Science ®Google Scholar
• Kopf A W, Rigel D S, Friedman R. J. Editorial—the rising incidence and mortality rate of malignant melanoma. J Dermatol Surg Oncol 1982; 8: 9, 760–1
   Google Scholar
• Kopf A W, Mintzis M, Bart R. S. Diagnostic accuracy in malignant melanoma. Arch Dermatol 1975; 111: 1291–2
   PubMedGoogle Scholar
• Levene A. On the histological diagnosis and prognosis of malignant melanoma. J Clin Pathol 1980; 22: 101–24
   Google Scholar
• Malec E, Eklund G, Lagerlöf B. Re-appraisal of malignant melanoma diagnosis in the Swedish Cancer Registry. Acta Pathol Microbiol Scand Sect A 1977; 85: 707–12
   Google Scholar
• Cooke R. A. Quality control in anatomic pathology: Experience in Australia and New Zealand. Appleton-Century Crofts. Pathology Annual, Part I, S C Sommers, P P Rosen, New York 1984; 221–48
   Google Scholar
• Truax H, Barnett R N, Hukill P B, et al. Effect of inaccurate pathological diagnosis on survival statistics for melanoma. Cancer 1966; 11: 1543–7
   Google Scholar
• Lee J AH, Yongchaiyudha S. Incidence of and mortality from malignant melanoma by anatomical site. J Natl Cancer Inst 1971; 47: 253–63
   PubMedGoogle Scholar
• Shaw H M, McGovern V J, Milton G W, et al. The female superiority in survival in clinical stage II cutaneous malignant melanoma. Cancer 1982; 49: 1941–4
   PubMed Web of Science ®Google Scholar
• Blois M S, Sagebiel R W, Abarbanel R M, et al. Malignant melanoma of the skin. Cancer 1983; 52: 1330–41
   PubMed Web of Science ®Google Scholar
• Cascinelli N, Morabito A, Bufalino R, et al. Prognosis of stage I melanoma of the skin. Int J Cancer 1980; 26: 733–9
   Google Scholar
• Rampen F. Malignant melanoma: sex differences in survival after evidence of distant metastasis. Br J Cancer 1980; 42: 52
   PubMed Web of Science ®Google Scholar
• Saxén E. Histopathology in cancer epidemiology. Pathology Annual: Nineteen Seventy-nine, Part I, S C Sommers, P P Rosen. Appleton, Century-Crofts, New York 1979; 203–17
   Google Scholar
• Consensus Conference. Precursors to malignant melanoma. JAMA 1984; 251: 1864–6
   Google Scholar
• Sagebiel R. W. Histopathology of borderline and early malignant melanomas. Am J Surg Pathol 1979; 3: 543–52
   Google Scholar
• Kuehnl-Petzoldt C, Keil H, Schoepf E. Prognostic significance of the patient's sex, tumor site, and mitotic rate in thin (≤ 1.5 mm) melanoma. Arch Dermatol Res 1984; 276: 151–5
   Google Scholar
• Clark W H, Jr, Ainsworth A M, Bernardino W. A. The developmental biology of primary human malignant melanoma. Semin Oncol 1975; 2: 83–103
   PubMedGoogle Scholar
• Magnus K. Prognosis in malignant melanoma of the skin. Cancer 1977; 40: 389–97
   PubMedGoogle Scholar
• Little J H, Holt J, Davis N. Changing epidemiology of malignant melanoma in Queensland. Med J Aust 1980; 1: 66–9
   Google Scholar
• Oettlé A. G. Epidemiology of melanoma in South Africa. Structure and control of the melanocyte, G Delia Porta, O Mühlbock. Springer Verlag, Heidelberg, Berlin 1966; 292–308
   Google Scholar
• ICD-O-Int. Classification of diseases for oncology. World Health Organization, GenevaSwitzerland 1976
   Google Scholar
• Crombie I. K. Racial differences in melanoma incidence. Br J Cancer 1979; 40: 185–93
   PubMed Web of Science ®Google Scholar
• Seiji M, Shsumi T. Statistical study on malignant melanoma in Japan (1961–1970). Tohoku J Exp Med 1972; 107: 115–25
   PubMed Web of Science ®Google Scholar
• Elwood J M, Lee J AH. Recent data on the epidemiology of malignant melanoma. Semin Oncol 1975; 2: 149–54
   PubMedGoogle Scholar
• McGovern V J, Shaw H M, Milton G W, et al. Is malignant melanoma arising in a Hutchinson's melanotic freckle a separate disease entity. Histopathology 1980; 4: 235–42
   PubMed Web of Science ®Google Scholar
• Green A, Little J H, Weedon D. The diagnosis of Hutchinson's melanotic freckle (Lentigo Maligna) in QueenslaZnd. Pathology 1983; 15: 33–5
   PubMed Web of Science ®Google Scholar
• MacDonald El J. (1976) Incidence and epidemiology of melanoma in Texas. Neoplasms of the skin and malignant melanoma. Proc. 20th Ann. Clin. Conf. 1975. M.D. Andersons Hosp. & Tumor Inst., Yr. Bk. Med. Publ., Chicago, 279–92
   Google Scholar
• Crombie I. K. Variation of melanoma incidence with latitude in North America and Europe. Br J Cancer 1979; 40: 774–81
   PubMed Web of Science ®Google Scholar
• Fears T R, Scotto J, Schneiderman M. A. Skin cancer, melanoma, and sunlight. Am J Public Health 1976; 66: 461–4
   PubMed Web of Science ®Google Scholar
• Houghton A, Flannery J, Viola M. V. Malignant melanoma in Connecticut and Denmark. Int J Cancer 1980; 25: 95–104
   PubMed Web of Science ®Google Scholar
• Elwood J M, Hislop T. G. Solar radiation in the etiology of cutaneous malignant melanoma in Caucasians. Natl Cancer Inst Monogr 1982; 62: 167–71
   PubMedGoogle Scholar
• MacKie R M, Aitchison T. Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in Scotland. Br J Cancer 1982; 46: 955–60
   PubMed Web of Science ®Google Scholar
• Stevens R G, Moolgavkar S. H. Malignant melanoma: Dependence of site-specific risk on age. Am J Epidemiol 1984; 119: 890–5
   PubMed Web of Science ®Google Scholar
• Ph C Ole, MacMahon B. Attributable risk percent in case-control studies. Br J Prev Soc Med 1971; 25: 242–4
   Google Scholar
• Acquavella J F, Wilkinson G S, Tietjen G L, et al. A melanoma case-control study at the Los Angeles National Laboratory. Health Physics 1983; 45: 587–92
   PubMed Web of Science ®Google Scholar
• Beral V, Evans S, Shaw H, et al. Cutaneous factors related to the risk of malignant melanoma. Br J Dermatol 1983; 109: 165–72
   PubMed Web of Science ®Google Scholar
• Holman C DJ, Armstrong B. K. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst 1984; 72: 257–66
   PubMed Web of Science ®Google Scholar
• Klepp O, Magnus K. Some environmental and bodily characteristics of melanoma patients. A case-control study. Int J Cancer 1979; 23: 482–6
   PubMed Web of Science ®Google Scholar
• Swerdlow A J, English J, MacKie R M, et al. Benign naevi associated with high risk of melanoma. Lancet 1984; 8395: 168
   Google Scholar
• Holman C DJ, Armstrong B. K. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: An analysis separating histogenetic types. J Natl Cancer Inst 1984; 73: 75–82
   PubMed Web of Science ®Google Scholar
• Clout I. Malignant melanoma. J Roy Coll Gen Pract 1972; 22: 508–20
   Google Scholar
• Pack G T, Gerber D M, Scharnagel I. M. End results in the treatment of malignant melanoma. Ann Surg 1952; 136: 905–11
   PubMed Web of Science ®Google Scholar
• MacDonald E. J. Malignant melanoma in Connecticut. In: Special Publication, NY Acad Sci 1948; 4: 71–81
   Google Scholar
• MacDonald El J. Malignant melanoma among negroes and Latin Americans in Texas. Pigment Cell Biology. Academic Press, New York 1959; 171–81
   Google Scholar